Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats
The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Rationale We previously reported that the central nucleus of the amygdala (CeA) plays a crucial role in the negative affective, rather than somatic, component of morphine withdrawal. However, numerous studies have reported that the central ascending noradrenergic system is implicated in morphine withdrawal syndrome, although the roles of the noradrenergic system within the CeA in the negative affective component remains less clear. Objectives The possible role of the noradrenergic system within the CeA in the negative affective component of morphine withdrawal was investigated. Methods The extracellular noradrenaline level within the CeA during naloxone-precipitated morphine withdrawal was measured using an in vivo microdialysis experiment on unanesthetized and freely moving rats. The effects of microinjection of beta-adrenoceptor antagonists into the bilateral CeA on the naloxone-precipitated morphine withdrawal-induced conditioned place aversion (CPA) and somatic signs were examined. Results The extracellular noradrenaline level within the CeA was transiently elevated during morphine withdrawal. Intra-CeA injections of beta-adrenoceptor antagonists propranolol (30 nmol per side) and timolol (10 nmol per side) significantly attenuated the morphine withdrawal-induced CPA. Similarly, beta(1)-antagonist atenolol (30 nmol per side) or beta(2)-antagonist butoxamine (30 nmol per side) significantly attenuated the CPA. In contrast, they did not affect morphine withdrawal-induced so…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Paxinos, G. (1985) · Cited by 3,715
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266 · cited 1×
“Nevertheless, in this study, we selected the bias-like protocol in order to nullify each rat’s initial preference, as previously discussed (for review, see Tzschentke 1998).”
MethodMoore, R. Y., & Bloom, F. E. (1979) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.02.030179.000553 · Cited by 1,118 · cited 1×
“It has been shown that the ascending NA system provides a dense innervation to the extended amygdala (Moore and Bloom 1979).”
BackgroundAGHAJANIAN, G. K. (1978) · Nature · doi:10.1038/276186a0 · Cited by 802 · cited 2×
“Although the locus coeruleus has long been considered to be essentially relevant to morphine withdrawal syndrome (Aghajanian 1978; Rasmussen et al. 1990; Koob et al. 1992; Maldonado et al. 1992), several studies have shown that neurotoxic lesion of NA neurons from the locus coeruleus did not affect them (Chieng and Ch…”
Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems
EVERITT, B. J., PARKINSON, J. A., OLMSTEAD, M. C., ARROYO, M., ROBLEDO, P., & ROBBINS, T. W. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09280.x · Cited by 708 · cited 1×
“Recently, it has been widely accepted that the extended amygdala is implicated in the positive and negative affective components of drug abuse (Everitt et al. 1999; Koob 1999).”
BackgroundDifferent types of fear-conditioned behaviour mediated by separate nuclei within amygdala
Killcross, S., Robbins, T. W., & Everitt, B. J. (1997) · Nature · doi:10.1038/41097 · Cited by 644 · cited 2×
“Furthermore, lesion of the CeA reduced fear-conditioned behavior (Campeau and Davis 1995; Killcross et al. 1997) and activation of the CeA in conscious animals elicited autonomic and behavioral effects indicative of anxiety-like responses (Feldman and Wiedenfeld 1998), suggesting that the CeA…”
BackgroundFallon, J. H., Koziell, D. A., & Moore, R. Y. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901800308 · Cited by 496 · cited 1×
“The CeA is known to be highly innervated by NA afferents via mainly ventral NA bundle from the A1/A2 cell groups and partly dorsal NA bundle from the locus coeruleus (Fallon et al. 1978; Zardetto-Smith and Gray 1990; Petrov et al. 1993; Asan 1998).”
BackgroundCampeau, S., & Davis, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02301.1995 · Cited by 479 · cited 2×
“Furthermore, lesion of the CeA reduced fear-conditioned behavior (Campeau and Davis 1995; Killcross et al. 1997) and activation of the CeA in conscious animals elicited autonomic and behavioral effects indicative of anxiety-like responses (Feldman and Wiedenfeld 1998), suggesting that the CeA…”
BackgroundNoradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462 · cited 4×
“2001), suggesting that the CeA might regulate the function of the BNST, which is also known to be clearly involved in stressful and aversive behavior (Henke 1984; Casada and Dafny 1991; Delfs et al. 2000).”
BackgroundInfluentialRasmussen, K., Beitner-Johnson, D., Krystal, J., Aghajanian, G., & Nestler, E. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02308.1990 · Cited by 439 · cited 2×
“Although the locus coeruleus has long been considered to be essentially relevant to morphine withdrawal syndrome (Aghajanian 1978; Rasmussen et al. 1990; Koob et al. 1992; Maldonado et al. 1992), several studies have shown that neurotoxic lesion of NA neurons from the locus coeruleus did not affect them (Chieng and Ch…”
Cited by
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
“…and a2 agonist) injected into the lateral bed nucleus of the stria terminalis blocked precipitated opiate withdrawalinduced place aversions (Delfs et al., 2000), and b-adrenergic antagonists produced similar effects when injected into the central nucleus of the amygdala (Watanabe et al., 2003).”
Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement
Koob, G. F. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.023 · Cited by 477
“The blockade of noradrenergic function in the bed nucleus of the stria terminalis also blocked opioid withdrawal–induced place aversions (34,35).”
BackgroundDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“, 2000) and by the administration of b1- and b2-adrenergic receptor antagonists in the CeA (Watanabe et al., 2003).”
BackgroundMethodSmith, R. J., & Aston-Jones, G. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0191-3 · Cited by 206
“Similar effects were observed with intra-CeA injections of beta-adrenoceptor antagonists (Watanabe et al. 2003).”
Background
Metadata
- Authors
- Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Satoh, Masamichi
- Venue
- Psychopharmacology
- Published
- 2003-10-01
- Volume
- 170
- Issue
- 1
- Pages
- 80-88
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2150805761
- Cited by
- 71
- References
- 59
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 5 · 2014: 7 · 2013: 3 · 2012: 6
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hoshi University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- central amygdala, noradrenergic system, morphine withdrawal, naloxone-precipitated withdrawal, conditioned place aversion, beta-blockers, propranolol, timolol, atenolol, butoxamine, somatic withdrawal signs
- MeSH terms
- Adrenergic beta-Antagonists, Amygdala, Animals, Avoidance Learning, Butoxamine, Conditioning, Operant, Male, Morphine, Naloxone, Narcotic Antagonists, Norepinephrine, Propranolol, Substance Withdrawal Syndrome, Timolol, Rats, Sprague-Dawley, Receptors, Adrenergic, beta-1, Receptors, Adrenergic, beta-2, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. https://app.cochat.ai/papers/10.1007/s00213-003-1504-0
- The paper
- Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M. (2003). Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology. https://doi.org/10.1007/s00213-003-1504-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.